ARCHIVES

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Lung Screening Advocates Say Verdict’s In, Attack NCI Randomized Trial As “Outdated.”

November 3, 2006

Chest X-Ray Produces Many False-Positive Results

January 27, 2006

NCAB Wants NCI To Avoid Setting Guidelines Regarding Health Policy

March 4, 1994

In Brief: Upton Still Pondering Location Of Centers, Other Program; Moves Could Involve DCCR

April 27, 1979

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

Cancer Control, Smoking Programs Reorganized

December 7, 1990